Significantly, in a low-grade inflammation state, such as established atherosclerosis, E2 promotes the destabilization of the atherosclerotic plaque by inducing the expression of molecules such as MCP-1 and MMP-9 and by increasing the activity of MMP-2 in the endothelial cells. Here, CCL2 is linked to atherosclerosis.